Nature Reviews Immunology (2018) https://doi.org/10.1038/s41577-018-0014-6 Published online 09 May 2018
In the initially published version of this article online in advance of print, a reference (Ajina, A. & Maher, J. Prospects for combined use of oncolytic viruses and CAR T-cells. J. Immunother. Cancer 5, 90 (2017)) was omitted in error from the following sentence: “The ability of oncolytic viruses to increase the expression of MHC class I molecules by cancer cells is also predicted to enhance ACT with TILs or TCR-engineered and chimeric antigen receptor (CAR) T cells that target tumour-specific antigens”. This has been corrected in the HTML and PDF versions of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bommareddy, P.K., Shettigar, M. & Kaufman, H.L. Author Correction: Integrating oncolytic viruses in combination cancer immunotherapy. Nat Rev Immunol 18, 536 (2018). https://doi.org/10.1038/s41577-018-0031-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-018-0031-5